본문바로가기

Advanced deep learning technology to provide unmatched performance


Core Technology that sets us apart

Our patented methods have been trained on thousands of cases to yield instantaneous and precise analysis of data.

world-class patents in:

  • 01

    Deep learning-based diagnostics
    technology

  • 02

    Diagnostic result visualization
    technology

  • 03

    Tissue slide indexing technology

  • 04

    Intelligent annotation technology


Awards & Recognition

  • Edison Awards - Silver
    DeepDx Prostate won Silver at the Edison Award 2021 in the Cellular Research & Disease Prevention category.
  • Camelyon17 Grand Challenge
    Our research team won the first place in Camelyon17, a global image analysis competition for detection and classification of breast cancer lymph nodes metastasis.

R&D for innovation in medical AI

AI-based Predictive Analytics
in Cancer Pathology
Development of prediction models by combining cancer pathology image analysis with oncology clinical data
Treatment
DeepDx Prostate is CE-marked, and MFDS-approved for clinical use in Korea. DeepDx solutions are not cleared by the FDA and for Research Use Only (RUO) in the United States. Contact Deep Bio for more information on system configuration, functionality and indications for use.